In a presidency marked by destructive health decisions, President Donald Trump’s proposal to lower prices for popular weight-loss drugs, known broadly as GLP-1s, is a rare bright spot. It’s unclear how much consumers will save under Trump’s plan, but if he succeeds at expanding access to these medications, he could help millions of Americans with treating chronic diseases.

See Full Page